Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-054451
Filing Date
2010-10-29
Accepted
2010-10-29 06:01:43
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17324_110q.htm 10-Q 2962635
2 EX-31.1 a10-17324_1ex31d1.htm EX-31.1 13290
3 EX-31.2 a10-17324_1ex31d2.htm EX-31.2 13226
4 EX-32.1 a10-17324_1ex32d1.htm EX-32.1 6037
5 EX-32.2 a10-17324_1ex32d2.htm EX-32.2 6341
  Complete submission text file 0001104659-10-054451.txt   9419748

Data Files

Seq Description Document Type Size
6 EX-101.INS ceph-20100930.xml EX-101.INS 1377562
7 EX-101.SCH ceph-20100930.xsd EX-101.SCH 30082
8 EX-101.CAL ceph-20100930_cal.xml EX-101.CAL 79491
9 EX-101.DEF ceph-20100930_def.xml EX-101.DEF 112991
10 EX-101.LAB ceph-20100930_lab.xml EX-101.LAB 396101
11 EX-101.PRE ceph-20100930_pre.xml EX-101.PRE 173798
Mailing Address 41 MOORES ROAD FRAZER PA 19355
Business Address 41 MOORES ROAD FRAZER PA 19355 6103440200
CEPHALON INC (Filer) CIK: 0000873364 (see all company filings)

EIN.: 232484489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19119 | Film No.: 101149631
SIC: 2834 Pharmaceutical Preparations